1. ind convening
  2. pharmacy growth collaborative

THMA Spring 2025 Pharmacy Growth Collaborative

May 14–16, 2025 | Conrad Ft. Lauderdale, FL


THMA Pharmacy Growth Collaborative

The Health Management Academy’s (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives together for candid discussions on key issues shaping pharmacy strategy. With peer-driven content and a retreat-style setting, this event fosters collaboration and meaningful connections.

THMA’s Pharmacy Growth Collaborative gathers twice each year—once in Spring and once in Fall—for an immersive, retreat-style event. The Pharmacy Growth Collaborative is opening space for additional industry members in 2025. We are seeking industry members that can bring important thought leadership and ideas to drive health forward.

Apply for Consideration

The Value of THMA Industry Convening

Bringing health systems and industry companies together to drive change through retreat-style forums is what we've specialized in for the past 25 years.

Join us this Spring and build genuine relationships with health system executives through intimate discussions, collaborative problem-solving and thought leadership exchange.

Apply for Consideration

Health System PGC Members


“The key component to this group is relationships. There is something about it that feels like a family reunion of getting back together every year.”

Todd Latz

CEO, GoHealth Urgent Care

The Health Management Academy Industry Partner

Spring 2025 Key Topics

Creating a Diversified Value Proposition

Defining a sustainable pharmacy value proposition that balances financial constraints with long-term impact

Ethical and Operational Challenges of Cell and Gene Therapy

Strategies for managing the high cost and complexity of these therapies, focusing on ethical considerations and operational efficiencies

Inflation Reduction Act

Exploring the impact of the IRA on pharmacy operations, including navigating CMS drug price negotiations

340B Challenges and Industry Collaboration

A deeper look at the 340B program, especially around pharmaceutical manufacturer collaboration and common challenges

GLP -1s

Explore strategies for health systems to manage the rising cost of GLP-1 therapies, focusing on sustainable approaches that balance financial considerations with patient access

Our Convening Experiences

Industry PGC Members


Accepting Applications Through April 23rd

Limited opportunity is available and is reserved for companies wanting to partner with Leading Health Systems with operating revenue of $2B or more. We will contact you with additional information within the next few days if your company is the right fit for this exclusive opportunity.

Apply for Consideration